期刊文献+

胆舒胶囊联合喜炎平治疗急性胆囊炎的机制研究 被引量:15

Mechanism of Danshu capsules combined with Xiyanping for acute cholecystitis
下载PDF
导出
摘要 目的:研究胆舒胶囊联合喜炎平治疗急性胆囊炎的机制,为急性胆囊炎患者的临床治疗提供更好的帮助。方法:选取门诊治疗的180例急性胆囊炎患者,随机将患者分为联合治疗组和对照组,每组90例,对照组患者采用常规治疗,联合治疗组在常规治疗基础上给予胆舒胶囊联合喜炎平的治疗。治疗前后检测并分析各组患者免疫细胞、胆囊炎相关指标、炎症因子和凝血功能相关指标。结果:与治疗前相比,两组患者经治疗后凝血功能指标[凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)]、CD8^+、胆囊炎相关指标[总胆红素、淀粉酶以及降钙素原(PCT)]、炎症因子[超敏C-反应蛋白(hsCRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)和白介素-10(IL-10)]显著降低,血清前白蛋白(PA)、免疫细胞(CD3^+、CD4^+和CD4^+/CD8^+)显著升高,差异存在统计学意义(P<0.05);凝血酶时间(TT)和纤维蛋白原(FIB)水平变化不明显(P>0.05)。与治疗后对照组相比,治疗后的联合治疗组凝血功能指标(PT和APPT)、CD8^+、胆囊炎相关指标(总胆红素、淀粉酶以及PCT)、炎症因子(hs-CRP、TNF-α、IL-6和IL-10)显著降低,PA、免疫细胞(CD3^+、CD4^+和CD4^+/CD8^+)显著升高,差异存在统计学意义(P<0.05);TT以及FIB水平变化不明显(P>0.05)。结论:胆舒胶囊联合喜炎平能够显著改善急性胆囊炎患者免疫细胞、胆囊炎相关指标、炎症因子和凝血功能相关指标,对急性胆囊炎患者的治疗具有积极的临床意义。 Objective:To observe the mechanism of Danshu capsules combined with Xiyanping for acute cholecystitis treatment in order to find better treatments for acute cholecystitis.Methods:A total of 180 patients with acute cholecystitis were selected and randomly divided into groups:the observation group(90people)and the control group(90people).The patient in the control group were treated with conventional therapy and the patients in the observation group were treated with Danshu capsules combined with Xiyanping on the basis of conventional therapy.Immunological cell,cholecystitis related factors,inflammatory factors,and the coagulation function related factors were detected and analyzed before and after treatment.Results:Coagulation function related factors(PT and APTT),CD8^+,cholecystitis related factors(total bilirubin,amylase and PCT),inflammatory factor(hs-CRP、TNF-α、IL-6和IL-10)in both groups after treatment significantly decreased.PA,immunological cell(CD3^+,CD4^+and CD4^+/CD8^+)significantly increased compared with that before treatment.The difference before and after treatment was considered to be statistically significant(P〈0.05).PP and the changes of FIB were not statistically significant(P〈0.05).Coagulation function related factors(PT and APTT),CD8^+,cholecystitis related factors(total bilirubin,amylase and PCT),and inflammatory factor(hs-CRP、TNF-α、IL-6和IL-10)in observation group after treatment decreased more significantly than that in control group,it was considered to be statistically significant(P〈0.05).Conclusion:Danshu capsules combined with Xiyanping can perfect effectively immunological cell,cholecystitis related factors,inflammatory factors and coagulation function related factors on patients with acute cholecystitis,it has important clinical significance for acute cholecystitis.
出处 《海南医学院学报》 CAS 2016年第23期2847-2850,共4页 Journal of Hainan Medical University
基金 江苏省卫生厅课题(JB201599)~~
关键词 急性胆囊炎 胆舒胶囊 喜炎平 联合治疗 Acute cholecystitis Danshu capsules Xiyanping Combination therapy
  • 相关文献

参考文献7

二级参考文献61

  • 1赵修春,姚春艳,李柏青,徐凤珍.流式细胞术检测小鼠中性粒细胞吞噬功能的方法学探讨[J].蚌埠医学院学报,2004,29(5):388-390. 被引量:16
  • 2李银平.抗生素和维生素C对普通上呼吸道感染没什么重要作用[J].中国危重病急救医学,2001(9):552.
  • 3陆再英,终南山.内科学[M].7版.北京:人民卫生出版社,2012:268-274.
  • 4居正华.维生素c预防呼吸道感染[J].国外医学参考资料:内科学分册,1975(1):39.
  • 5桂永浩,申昆玲,毛萌.小儿腹泻病//小儿内科学高级教程[M].北京:人民军医出版社,2012:145-154.
  • 6沈晓明,王卫平.腹泻病//儿科学[M].7版.北京:人民卫生出版社,2008:246-256.
  • 7诸福棠,胡亚美,江载芳.实用儿科学(腹泻病)[M].7版.北京:人民卫生出版社,2005:1286-1299.
  • 8王慕邀,主编.全国高等医药院校儿科学[M].5版.北京:人民卫生出版社,2003:256.
  • 9Jones N E, Hayland D K. Implementing nutrition guidelines in the critical care setting[ J ]. JAMA,2009,300 (23) :2798.
  • 10Rayes N, Hansens S, Seehofer D, et al. Early enteral supply of fi- ber and lactobacilli versus conventional nutrition : a controlled trial in patients with major abdominal surgery [ J ]. Nutrition, 2002, 18(7/8) :609.

共引文献104

同被引文献144

引证文献15

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部